Drugnews|藥時事

U-Neuron

永立榮生醫股份有限公司

6973 · Emerging Stock Board

U-Neuron is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.

Pipeline

AssetTarget / mechanismStageIndicationRegionSource dateSource
UB003—Preclinical / PIND preparationDry eye; neurotrophic keratitis——Company disclosure

Key events

No verified events in the past twelve months.

Related Drugnews articles

No related articles in this language.